Contents

Current Drug Targets, Volume 4 - Number 6

Preface [Hot Topic:Inflammatory Markers and Mediators: Emerging Therapeutic Targets in Diabetes, Cardiovascular and Metabolic Disorders (Guest Editor: Samuel Dagogo-Jack, MD)].

, 4(6): iii

Samuel Dagogo-Jack


DOI: 10.2174/1389450110304060iii




Drug Resistance to Cytotoxic Nucleoside Analogues

, 4(6): 443 - 460

L. Jordheim, C. M. Galmarini and C. Dumontet


DOI: 10.2174/1389450033490957




Non-steroidal Anti-inflammatory Drugs and Cyclooxygenase in Alzheimer s Disease

, 4(6): 461 - 468

Jeroen J.M. Hoozemans, Robert Veerhuis, Annemieke J.M. Rozemuller and Piet Eikelenboom


DOI: 10.2174/1389450033490902




P-glycoprotein - A Novel Therapeutic Target for Immunomodulation in Clinical Transplantation and Autoimmunity?

, 4(6): 469 - 476

S. Pendse, H. M. Sayegh and H. M. Frank


DOI: 10.2174/1389450033490894




Novel Cardiovascular Risk Factors and Macrovascular and Microvascular Complications of Diabetes

, 4(6): 477 - 486

P. Theuma and V. A. Fonseca


DOI: 10.2174/1389450033490939




Insulin Resistance as a Proinflammatory State: Mechanisms, Mediators, and Therapeutic Interventions

, 4(6): 487 - 492

Rajesh Garg, Devjit Tripathy and Paresh Dandona


DOI: 10.2174/1389450033490920




Activated T Lymphocytes in Type 2 Diabetes: Implications From in Vitro Studies

, 4(6): 493 - 503

Frankie B. Stentz and Abbas E. Kitabchi


DOI: 10.2174/1389450033490966




Aldosteronism in Heart Failure: A Proinflammatory / Fibrogenic Cardiac Phenotype. Search for Biomarkers and Potential Drug Targets

, 4(6): 505 - 516

Karl T. Weber, Ivan C. Gerling, Mohammad F. Kiani, Ramareddy V. Guntaka, Yao Sun, Robert A. Ahokas, Arnold E. Postlethwaite and Kenneth J. Warrington


DOI: 10.2174/1389450033490948




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science